Related Experiment Videos
Chemotherapy of disseminated Merkel-cell carcinoma
1Hematology-Oncology Service, Walter Reed Army Medical Center, Washington D.C.
American Journal of Clinical Oncology
|August 11, 1991
Abstract:
Six patients developed metastatic merkel-cell carcinoma and were treated with a combination chemotherapy frequently used for small-cell lung cancer. Five of six patients had a complete response for a median of 3.5 months. Overall survival from initiation of chemotherapy was a median of 6.5 months. Two patients died from major complications of therapy.